Publication | Open Access
Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs
33
Citations
46
References
2020
Year
Exoribonuclease ActivityAntiviral CompoundMedicineAntiviral Drug DevelopmentAntiviral TherapyVirologyPharmacotherapyAntiviral DrugPharmacologySars-cov-2 VirusDrug DiscoveryChain Terminating Drugs
| Year | Citations | |
|---|---|---|
Page 1
Page 1